Clincosm LogoSign in Get a demo

ccrcc

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial in United States (Oral NKT2152)

Recruiting
  • ccRCC
  • +9 more
  • Oral NKT2152
  • Scottsdale, Arizona
  • +6 more
Oct 17, 2022

Advanced Solid Tumors, Solid Tumor, Solid Carcinoma Trial (Belzutifan)

Active, not recruiting
  • Advanced Solid Tumors
  • +15 more
  • (no location specified)
Sep 16, 2022

ccRCC, RCC, Kidney Cancer Trial in United States (MK-3795, Nivolumab, Cabozantinib)

Active, not recruiting
  • ccRCC
  • +4 more
  • Los Angeles, California
  • +24 more
Jul 18, 2022

Solid Tumor, Clear Cell Renal Cell Carcinoma, TNBC - Triple-Negative Breast Cancer Trial in United States (CB-839, Talazoparib)

Terminated
Has Results
  • Solid Tumor
  • +6 more
  • Birmingham, Alabama
  • +8 more
Feb 16, 2022